A fifty-six-year-old executive in Wuse develops episodic chest tightness on early-morning walks, dismisses it, and three months later notices that erections he was used to having are no longer dependable. He tells nobody. The chest tightness he reads as too much pepper soup the night before. The other thing he reads, more reluctantly, as ageing. On a Saturday afternoon at the National Hospital car park he stops at a vendor who sells two things — phone chargers and small white pills in foil sleeves — and buys a strip of "sildenafil 100 mg" for ₦4,500, which is what the vendor charges expatriates. He takes one that evening. It works. He buys more.
Two years later, his driver takes him to A&E with crushing central chest pain and an ECG that announces a STEMI. The interventional cardiologist who places the stent treats the cardiac event as a primary diagnosis — which, by the time the patient reached the catheter lab, it was. None of the prescriptions in the Maitama drawer enter the chart. The strip of sildenafil that has been in his pocket for the last fourteen months does not enter the chart. The agbo his sister has been bringing every other Sunday does not enter the chart. The cardiology team treats the artery, the patient survives, and the case is written up in the discharge summary as a previously well fifty-eight-year-old who suffered an acute myocardial infarction.
He was not previously well. He had been receiving an early-warning signal from his cardiovascular system for two years, and translating it as a personal failing that required a pill from a car park.
This piece is for that man, and for the doctor who could have seen the warning if anyone had given him the chance.
What erectile dysfunction actually is
Erectile dysfunction is not a sexual diagnosis. It is a cardiovascular diagnosis that announces itself through the smallest arteries in the body before the larger ones fail. Penile arteries are 1 to 2 millimetres across. Coronary arteries are 3 to 4 millimetres across. The same atherosclerotic process, the same endothelial damage, the same impairment of nitric-oxide-dependent vasodilation that will eventually narrow a coronary vessel into a critical stenosis shows up first in the smaller vessels — because smaller vessels are simply less forgiving of the same percentage of obstruction.
This is not a marginal idea in clinical cardiology. The European Society of Cardiology, the American College of Cardiology, and the British Joint Societies' JBS3 framework all now treat new-onset erectile dysfunction in a man over forty as an independent predictor of a major adverse cardiac event within three to five years, with risk magnitude comparable to current smoking. The published time lag — between a man first noticing reliable difficulty with erections and the same man arriving at a catheter lab — is approximately three years on average.
Three years is enough time. It is enough time to start a statin, to control the blood pressure that was not being controlled, to escalate the diabetic management that had drifted, to do an exercise test, to do a coronary calcium score, to walk the patient through what is coming and prevent it. Three years is the difference between an avoidable infarction and an unavoidable one. The earliest, cheapest, most decisive intervention point in a man's cardiovascular life is the doctor's visit during which he mentions, almost in passing, that something has changed about his sex life.
The intervention point exists. In Nigeria, the visit does not happen.
Why the canary sings louder here
Roughly three in ten Nigerian adults now live with hypertension. Type 2 diabetes affects 5 to 6 percent of the adult population and is rising. These two conditions are the two most powerful amplifiers of erectile dysfunction risk, because the underlying mechanism — small-vessel endothelial dysfunction — is exactly the mechanism each of them attacks. Roughly half of Nigerian diabetic men over fifty already meet criteria for erectile dysfunction by validated questionnaire. Roughly a third of Nigerian men with sustained hypertension do. The same population is also more likely to have undiagnosed dyslipidaemia, less likely to be on a statin, less likely to be physically active, and more likely to smoke. Every one of those vectors compounds the canary's signal.
What this means in practice is that the population that most needs the warning to be received is also the population that gives it most loudly. The Nigerian man in his fifties with poorly controlled hypertension and undiagnosed pre-diabetes is the textbook case for a clinical conversation that catches him before his cardiologist does. Internationally, this conversation has become routine in primary care. In Nigeria, it has not. The reasons it has not are structural, and they are why this piece exists.
The three reasons self-medication is worse here than in Europe
The European problem with erectile-dysfunction self-medication is real but contained. Most European men, even those buying pills off-licence, are buying real pharmaceuticals from semi-regulated online sources, and most have at least intermittent contact with a general practitioner. The Nigerian problem is structurally worse for three reasons that compound.
The first is the counterfeit and unprescribed pharmaceutical market. Sildenafil, tadalafil, and their analogues are sold openly in Nigerian open markets, in car parks, in hospital perimeter pharmacies, by roadside vendors, and through informal online channels. NAFDAC has flagged counterfeit erectile-dysfunction drugs as one of their most-seized product categories for years running. The pills men actually swallow are frequently underdosed — leaving the user convinced his condition has worsened, when in fact he has taken a sugar tablet — overdosed, or adulterated with other agents the buyer is not informed about. Either way, the data the patient is generating about his own physiology is unreliable. Whether the pill worked tells him nothing about whether the underlying problem is worsening.
The second is the herbal "manpower" market that presents as alternative medicine but is not. Multiple published analyses of West African herbal sexual-performance products have found undisclosed pharmaceutical adulteration — sildenafil, tadalafil, or close chemical analogues mixed into products marketed as natural bitters and tonics. The man drinking the bitters believes he is taking a herbal supplement; he is in fact taking an uncontrolled dose of a PDE5 inhibitor with no knowledge of its strength, no expiry control, no manufacturing oversight, and no warning of contraindications. The cultural framing of these products as gentler, more natural, and less foreign than the white doctor's prescription is, in this specific category, demonstrably false.
The third is the nitrate interaction nobody is checking. Older Nigerian men on chronic medication for ischaemic heart disease are frequently taking nitrates — isosorbide mononitrate, isosorbide dinitrate, glyceryl trinitrate, in various trade names and combinations. Combining nitrates with a PDE5 inhibitor causes severe, sometimes fatal hypotension. In a healthcare system where a man can buy the pill on the same street where another vendor sells his cardiac medications, with neither vendor talking to the other, this happens. It is just not being reported as the cause of death — sudden cardiac collapse in a fifty-eight-year-old man with known hypertension is recorded as a myocardial event, full stop. The pharmacy receipt is not in the autopsy. The strip in the pocket is not in the autopsy.
None of these three problems exists in isolation. The same patient is often consuming the counterfeit pill on Friday, the bitters on Sunday, and the nitrate tablet every morning, and no clinician anywhere has the complete picture of what is in his bloodstream this week. That patient, when something finally fails, will be admitted as a previously well man.
What is lost when the conversation does not happen
The argument for raising erectile dysfunction with a physician is not the relief of the symptom. The relief of the symptom is the cheap part. The expensive part — the part that justifies the relationship in the first place — is what the doctor does with the information.
What a physician who knows your file does, when you mention that something has changed about your erections, is not write a prescription. The prescription, when appropriate, comes later. What the physician does first is sit with the chart for thirty seconds and conclude that an asymptomatic-on-paper fifty-five-year-old man with a borderline blood pressure he has not been tracking, an HbA1c the patient does not realise is now in pre-diabetic range, and a strong family history of cardiovascular disease is in fact symptomatic — and the symptom he has just disclosed is cardiology's earliest available warning. From that conclusion, an entirely different next six months unfold. A serious blood-pressure baseline. A fasting lipid profile. An HbA1c if it has been a year. Possibly a coronary calcium score. Definitely a statin if the lipid profile supports it. A hard conversation about sodium. A longer conversation about exercise. A careful look at whether his current antihypertensive regimen is itself contributing to the erectile dysfunction — some are, some are not, some can be substituted, and the physician knows which. And only after all of that, the appropriate PDE5 inhibitor, prescribed at the correct dose, from a regulated source, with the patient's full medication list reviewed for nitrate interaction.
None of that happens at the car park.
That sequence is what concierge medicine, when properly built, actually buys. Not the pill. The visit at which the pill is the smallest item discussed.
How we handle it at Kinedic
Our position on this — and we are aware it is not the position most Nigerian primary-care practices have taken publicly — is that erectile dysfunction is a standard cardiovascular review item in any male member's annual physical from age forty onward, raised by the physician, not waited on. The same way blood pressure is checked without the patient having to ask. The same way HbA1c is run without the patient having to know what HbA1c stands for. A direct, brief, professional question, asked in a setting designed for the conversation not to feel like an ambush. Most men, asked plainly, answer plainly. The ones who do not are flagged for a quieter follow-up later in the visit.
When the answer reveals that something has changed, the conversation then unfolds into the clinical sequence described above. The screening cascade follows. The medication review follows. If a PDE5 inhibitor is appropriate, it is prescribed at the correct dose, from a regulated supply chain, with the patient's full medication list checked for nitrate exposure. The man does not return to the car park.
The harder version of the conversation is for the man who has been on the car-park pills, or the bitters, for years already. That is most of the men this piece is written for. The clinical work in that case is reconstructive — a careful enquiry into everything that has actually been ingested and how often, a baseline assessment of where the cardiovascular damage already is, and a candid acknowledgement that some of what has been lost cannot be recovered. What can still be done is to stop the loss accelerating. For most men this discovers more remaining margin than they had assumed.
Closing
The cultural script that says erectile dysfunction is a private problem to be solved with a private pill is, in 2026 Nigeria, a script that is killing men. Not figuratively. The pathway from the first missed signal to the catheter lab is reasonably well mapped now, and a great many men who arrive at the second event were given the opportunity, two or three years earlier, to be in a different conversation. They were not in that conversation because the structure for it did not exist around them.
If you are a man in your forties or fifties reading this and finding it uncomfortable, that is not the wrong response. It is the correct one. The next step is not to discuss the discomfort with the internet. It is to discuss it with a physician who will hold the conversation properly, place it in your medical context, and act on what it tells him.
We do that. The first conversation is private and costs nothing.